NYSEARCA:IDNA

iShares Genomics Immunology and Healthcare ETF Stock Forecast, Price & News

$49.79
+0.17 (+0.34 %)
(As of 06/11/2021 12:00 AM ET)
Add
Today's Range
$49.42
$49.86
50-Day Range
$43.63
$49.79
52-Week Range
$34.32
$55.03
Volume40,008 shs
Average Volume78,083 shs
Market Capitalization$308.70 million
P/E RatioN/A
Dividend Yield0.18%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive IDNA News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer iShares
Fund NameiShares Genomics Immunology and Healthcare ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IDNA
Inception Date6/11/2019
Fund ManagerRachel Aguirre, Jennifer Hsui, Alan Mason, Greg Savage, Amy Whitelaw
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNYSE FactSet Global Genomics and Immuno Biopharma Index
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$307.60 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.47%
Other Expenses0.00%
Total Expenses0.47%
Fee Waiver0.00%
Net Expenses0.47%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market Maker

Geographic Exposure of IDNA

Currency Exposure of IDNA

Sector Exposure of IDNA

Industry Exposure of IDNA

speech bubbles
speech bubbles











iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Frequently Asked Questions

What stocks does MarketBeat like better than iShares Genomics Immunology and Healthcare ETF?

Wall Street analysts have given iShares Genomics Immunology and Healthcare ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iShares Genomics Immunology and Healthcare ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has iShares Genomics Immunology and Healthcare ETF's stock been impacted by COVID-19?

iShares Genomics Immunology and Healthcare ETF's stock was trading at $26.77 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IDNA shares have increased by 86.0% and is now trading at $49.79.
View which stocks have been most impacted by COVID-19
.

Is iShares Genomics Immunology and Healthcare ETF a good dividend stock?

iShares Genomics Immunology and Healthcare ETF pays an annual dividend of $0.09 per share and currently has a dividend yield of 0.18%.
View iShares Genomics Immunology and Healthcare ETF's dividend history.

What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Genomics Immunology and Healthcare ETF investors own include Pfizer (PFE), Gilead Sciences (GILD), Intel (INTC), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Novavax (NVAX), Canadian Natural Resources (CNQ), QUALCOMM (QCOM), SPDR S&P Biotech ETF (XBI) and Bristol-Myers Squibb (BMY).

What is iShares Genomics Immunology and Healthcare ETF's stock symbol?

iShares Genomics Immunology and Healthcare ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IDNA."

Who are iShares Genomics Immunology and Healthcare ETF's major shareholders?

iShares Genomics Immunology and Healthcare ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Wealthcare Advisory Partners LLC (1.44%), Baird Financial Group Inc. (0.71%), Cambridge Investment Research Advisors Inc. (0.38%), Outlook Wealth Advisors LLC (0.26%), Flow Traders U.S. LLC (0.20%) and Sigma Planning Corp (0.10%).

Which major investors are selling iShares Genomics Immunology and Healthcare ETF stock?

IDNA stock was sold by a variety of institutional investors in the last quarter, including James Investment Research Inc..

Which major investors are buying iShares Genomics Immunology and Healthcare ETF stock?

IDNA stock was bought by a variety of institutional investors in the last quarter, including Baird Financial Group Inc., Wealthcare Advisory Partners LLC, Flow Traders U.S. LLC, Wealthcare Capital Management LLC, Cambridge Investment Research Advisors Inc., Outlook Wealth Advisors LLC, and Sigma Planning Corp.

How do I buy shares of iShares Genomics Immunology and Healthcare ETF?

Shares of IDNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares Genomics Immunology and Healthcare ETF's stock price today?

One share of IDNA stock can currently be purchased for approximately $49.79.

How much money does iShares Genomics Immunology and Healthcare ETF make?

iShares Genomics Immunology and Healthcare ETF has a market capitalization of $308.70 million.


This page was last updated on 6/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.